Krystal Biotech (KRYS) Inventory Average (2023 - 2025)
Krystal Biotech (KRYS) has disclosed Inventory Average for 3 consecutive years, with $39.1 million as the latest value for Q4 2025.
- Quarterly Inventory Average rose 73.23% to $39.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.1 million through Dec 2025, up 73.23% year-over-year, with the annual reading at $33.5 million for FY2025, 99.99% up from the prior year.
- Inventory Average hit $39.1 million in Q4 2025 for Krystal Biotech, up from $34.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $39.1 million in Q4 2025 to a low of $6.1 million in Q4 2023.
- Historically, Inventory Average has averaged $21.9 million across 3 years, with a median of $22.5 million in 2024.
- Biggest five-year swings in Inventory Average: soared 267.68% in 2024 and later skyrocketed 73.23% in 2025.
- Year by year, Inventory Average stood at $6.1 million in 2023, then skyrocketed by 267.68% to $22.5 million in 2024, then surged by 73.23% to $39.1 million in 2025.
- Business Quant data shows Inventory Average for KRYS at $39.1 million in Q4 2025, $34.3 million in Q3 2025, and $30.5 million in Q2 2025.